Emicizumab-kxwh Subcutaneous and Posaconazole Delayed-Release Tablets
Determining the interaction of Emicizumab-kxwh Subcutaneous and Posaconazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Posaconazole Injection
- Emicizumab-kxwh Subcutaneous-Posaconazole Intravenous
- Emicizumab-kxwh Subcutaneous-Posaconazole Oral Suspension
- Emicizumab-kxwh Subcutaneous-Posaconazole oral/injection
- Emicizumab-kxwh Subcutaneous-Posaconazole Tablets
- Emicizumab-kxwh Subcutaneous-PosiFlush flush
- Posaconazole Delayed-Release Tablets-Emla
- Posaconazole Delayed-Release Tablets-Emla Topical
- Posaconazole Delayed-Release Tablets-Emo-Cort Scalp Solution Topical application
- Posaconazole Delayed-Release Tablets-Emo-Cort Topical application
- Posaconazole Delayed-Release Tablets-Emoquette
- Posaconazole Delayed-Release Tablets-Empagliflozin